M. Alexander Otto, PA, MMSc

Articles by M. Alexander Otto, PA, MMSc

Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib - medscape.com

Health August 12, 2026

Following unprecedented results from the RASolute 302 trial, cancer centers across the US are making daraxonrasib available to patients ahead of FDA approval. The RAS inhibitor has been in the news οΏ½...